COVID-19 Unveils Social Media Might: Is Pharma Listening Hard Enough?

COVID-19 has generated a mind-boggling one billion-plus mentions on social media, unleashing unstructured big data rich in insights. Experts explain why pharma may well want  to“listen in” more raptly to such conversations across therapy areas while shaping some aspects of business strategy.